Gene Therapy Trials for Hemophilia A: Where We Are and What Comes Next

Here’s what we’ll discuss
  • Icon

    A general overview of the clinical trial process

  • Icon

    Details on the design of the BioMarin gene therapy clinical trial program for hemophilia A (BMN 270) and its current progress

  • Icon

    BioMarin's approach to advocacy for the hemophilia community

Interested in expanding your knowledge?

Sign up for information about upcoming events, new resources, and the latest from BioMarin.

Are you a U.S. resident?

This content is intended for US participants only.